Bristol-Myers to acquire DuPont Pharma

BMY will purchase DuPont Pharmaceuticals, a wholly-owned subsidiary of DuPont (DD), for $7.8 billion in cash. DuPont Pharmaceuticals posted $1.5 billion in sales last year. BMY said that key products ...